Wednesday, March 13, 2019 7:32:35 PM
52 Week Change: 22.080
90-Day Moving Average: 40.506
Beta: 3.0993
52 Week High: 59.2500
52 Week Low: 16.7370
50 Day Moving Average: 49.1000
200 Day Moving Average: 34.0756
Shares Short: 14757846.00
Shares Short Prior Month: 10509287.00
Short Ratio: 0.8100
Forecast data:
52 Week High: 77.497
52 Week Low: 47.199
45-Day Moving Average: 49.696
90-Day Moving Average: 50.995
Stock Info
General
Country Name: USA
Exchange: NYSE
Sector: Healthcare
Type: Common Stock
Industry: Drug Manufacturers - Specialty & Generic
Pivot, Resistance Levels and Support Levels
For Stop Loss and Trading Targets
Calculation For Trading:
Resistance Level (R3): 48.605
Resistance Level (R2): 48.220
Resistance Level (R1): 47.490
Pivot Point: 47.105
Support Level (S1): 46.375
Support Level (S2): 45.990
Support Level (S3): 45.260
90-Day Moving Average: 40.506
Beta: 3.0993
52 Week High: 59.2500
52 Week Low: 16.7370
50 Day Moving Average: 49.1000
200 Day Moving Average: 34.0756
Shares Short: 14757846.00
Shares Short Prior Month: 10509287.00
Short Ratio: 0.8100
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM